CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders

NCT02500602 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
144
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

VA Office of Research and Development

Collaborators